Tata India Pharma & HealthCare Fund Regular-Growth
Tata India Pharma & HealthCare Fund Regular-Growth: Mutual Fund Overview
Tata India Pharma & HealthCare Fund Regular-Growth is an Sectoral-Pharma mutual fund with over 10.2 years of performance history. The scheme manages an AUM of ₹1300.81 Cr and has a NAV of ₹29.8641. It is rated '3' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 8.98%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 8.98% at 12 Mar 2026 07:06 PM
Fund Details
NAV 29.8641
Sub-Type Sectoral-Pharma
Rating 3
Min. SIP Amount ₹100.0
Fund Age(Year) 10.2
Fund Size(in Crores) 1300.81
Fund Performance
1 Month -0.2%
3 Month -1.81%
6 Month -3.63%
1 Year 8.98%
3 Year 24.1%
5 Year 15.32%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (97.56%) Market Cap Small Cap 40.14 Large Cap 32.34 Mid Cap 25.08 Top Sectors Healthcare 94.23 Chemicals 3.33 Top Holding Glaxosmithkline Pharma 1.82 Lupin 3.08 Dr. Lal Pathlabs 2.71 Dr. Reddy's Laboratories 3.04 Rainbow Children's 3.83 Fortis Healthcare 3.27 Divi's Laboratories 5.94 Laxmi Dental 0.02 Bayer CropScience 3.33 Mankind Pharma 3.4 Max Healthcare Institute 6.78 Sun Pharmaceutical Industries 9.66 Ajanta Pharma 2.06 Syngene International 2.39 Neuland Laboratories 2 Sai Life Sciences 3.25 Dr. Agarwal's Health Care 0.07 Vijaya Diagnostic Centre 1.55 CORONA Remedies 0.99 Sanofi India 1.99 Metropolis Healthcare 3.13 Cipla 4.55 Global Health 1.5 Hikal 0.6 Healthcare Global Enterprises 5.04 Alkem Laboratories 2.15 Jubilant Pharmova 0.07 Ipca Laboratories 0 Krishna Institute 2.64 Abbott India 5.6 FDC 1.82 Apollo Hospitals Enterprise 5 JB Chemicals 3.21 Torrent Pharmaceuticals 1.07
Debt & Others (2.44%) Sector Allocation Repo 0.2 Cash/Net Current Assets 2.24 Debt Credit Ratings Debt Category Others 2.44
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.12%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Rajat Srivastava
Education Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Meeta Shetty
Education Ms. Shetty is Bachelor in Economics and CFA Charterholder
Experience Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 22
Date of Incorporation 2015-12-28
Total AUM 232819.21
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
